This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reed, J C Articles by Prystowsky, M B Search for Related Content PubMed PubMed Citation Articles by Reed, J C Articles by Prystowsky, M B

 Previous Article  |  Next Article 

Mol Cell Biol. 1985 December; 5(12): 3361-3368

Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.

ABSTRACT

The cellular oncogene c-myc has been implicated in the regulation of growth of normal and neoplastic cells. Recently, it was suggested that c-myc gene expression may control the G0----G1-phase transition in normal lymphocytes that were stimulated to enter the cell cycle by the lectin concanavalin A (ConA). Here we describe the effects of purified recombinant interleukin 2 (rIL2) and of ConA on levels of c-myc mRNA in the noncytolytic murine T-cell clone L2. In contrast to resting (G0) primary cultures of lymphocytes, quiescent L2 cells have a higher RNA content than resting splenocytes and express receptors for interleukin 2 (IL2). Resting L2 cells are therefore best regarded as early G1-phase cells. Purified rIL2 was found to stimulate the rapid accumulation of c-myc mRNA in L2 cells. Levels of c-myc mRNA became maximal within 1 h and declined gradually thereafter. In contrast, ConA induced slower accumulation of c-myc mRNA in L2 cells, with increased levels of c-myc mRNA becoming detectable 4 to 8 h after stimulation. Experiments with the protein synthesis inhibitor cycloheximide demonstrated that the increase in levels of c-myc mRNA that were induced by ConA was a direct effect of this lectin and not secondary to IL2 production. Cyclosporin A, an immunosuppressive agent, markedly reduced the accumulation of c-myc mRNA that was induced by ConA but only slightly diminished the accumulation of c-myc mRNA that was induced by rIL2. Taken together, these data provide evidence that (i) c-myc gene expression can be regulated by at least two distinct pathways in T lymphocytes, only one of which is sensitive to cyclosporine A, and (ii) the accumulation of c-myc mRNA can be induced in T cells by IL2 during the G1 phase of the cell cycle.

This article has been cited by other articles:

• Brundage, K. M., Schafer, R., Barnett, J. B. (2004). Altered AP-1 (Activating Protein-1) Activity and c-jun Activation in T Cells Exposed to the Amide Class Herbicide 3,4-Dichloropropionanilide (DCPA). Toxicol Sci 79: 98-105 [Abstract] [Full Text]  
• Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M., Hirano, T. (1999). STAT3 Is Required for the gp130-mediated Full Activation of the c-myc Gene. J. Exp. Med. 189: 63-73 [Abstract] [Full Text]  
• Hoxie, J., Alpers, J., Rackowski, J., Huebner, K, Haggarty, B., Cedarbaum, A., Reed, J. (1986). Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234: 1123-1127 [Abstract]  
• Stern, J., Smith, K. (1986). Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 233: 203-206 [Abstract]